PSI Newsletter 2025

Read the updates and insights in the PSI Newsletter: Issue 1, 2025

• Continuing Professional Development (CPD) system changes
• Election for appointment of pharmacists to PSI Council
• Expansion of the role of pharmacy
• Learning from a PSI Inquiry
• Healthmail clarification
• Valproate (Epilim▼) materials for patients
• Safe dispensing of controlled drugs
• Fitness to practise and mediation outcomes
• HSE-AMRIC resource
• Spring COVID-19 booster campaign
• Pharmacy needle exchange survey
• Opportunities for pharmacists on HSE working groups

Read the updates and insights in the PSI Newsletter: Issue 2, 2025

• Updates to vaccination and emergency medicines training requirements for pharmacists
• Expansion of pharmacy services: Public consultation on proposed education and training rules and guidelines
• Public consultation: Registration Rule changes to facilitate a delineated model of operation
• Accreditation of MPharm degree programmes
• ePortfolio Review 2025/2026
• EMA review on Finasteride and Dutasteride
• Direct healthcare professional communications – feasibility study
• PSI Council appointments
• Fitness to practise matter
• Safe dispensing of Roaccutane® (isotretinoin)
• Updates to PSI Guidance on Good Dispensing Practice-High Tech Arrangements
• Ceftriaxone use in long term residential care facilities
• PPC Annual Reports
• Notice on hub and spoke model of dispensing
• Changes to pharmacy layouts and floorplans